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Summary 
Cancer incidence in Australia is projected to rise due to an expected increase in both the 
underlying cancer rates and in the Australian population over the age of 65. As a result, 
planning for cancer treatment services must anticipate future trends and age structures. 
This report presents projections of the number of new cases of cancer (all cancers combined) 
diagnosed in Australia from 2014 to 2024, by state and territory health planning regions.  
Projections of the number of new cancer cases for each health planning region have been 
calculated using trends in cancer incidence from 1997 to 2010—the latter being the most 
recent year for which national cancer incidence data are available—and population 
projections provided by the Australian Government Department of Health.  
Key findings 
In 2024, an estimated 169,648 new cases of cancer are expected to be diagnosed in Australia, 
an average annual increase of 3.3% per year from 2010 (Table 2.1).  
The proportional increase is expected to vary between states and territories. The largest 
increase is expected in Western Australia (5.0% per year), followed by the Australian Capital 
Territory (4.4%), Queensland (4.2%), the Northern Territory (3.9%) and Victoria (3.2%). New 
South Wales (2.5% per year), Tasmania (2.3%) and South Australia (1.9%) are expected to 
have the smallest annual proportional increases in cancer incidence rates. 
Important notes 
Projections are, by nature, estimates at best and are subject to a number of limitations 
and assumptions. The combined impact of these is such that the Australian Institute of 
Health and Welfare (AIHW) presents these projections only as approximate statistical 
extrapolations of the period 1997 to 2010 as a means to illustrate future changes that 
would occur if the stated assumptions were to apply over the projection interval. The 
AIHW can offer no guarantees as to the true predictive value of these estimates out to 
2024. 
These estimates were developed for the Australian Government Department of Health 
for their planning purposes. The methods used to derive projected cancer incidence 
counts for this report were developed so as to be consistent and comparable across all 
jurisdictional health planning regions.  
The projection methodology does not take into account variations in historical incidence 
at the health planning region level. The resulting incidence projections also do not 
account for the future use of radiation oncology services by residents of other states, 
territories or health planning regions. For further information see the ‘Limitations and 
assumptions’ section in Chapter 1.  
The projected estimates presented in this report may differ from those published by the 
states and territories, due to differences in the underlying methodologies. In particular, 
state and territory cancer registries have access to additional information that could lead 
their projections to be more accurate at the jurisdictional level. 
Consumers are advised to exercise caution and consider the methodology when applying 
these estimates to other purposes.  
The state and territory cancer registries have given approval to publish these data.
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1 Introduction 
Background 
Radiation oncology (or radiotherapy) is one of the main treatment modalities contributing to 
the cure or palliation of many cancer patients. Most recent evidence estimates that 
approximately 48% of new notifiable cancers in Australia should receive at least one course 
of radiotherapy, referred to as the optimal radiotherapy utilisation rate (Barton et al. 2013). 
Demand for radiotherapy treatment services is highly dependent on the number of new 
cancer cases diagnosed. Hence, estimates of future cancer incidence play an important role in 
health resource planning. As part of the planning process for new radiotherapy centres, the 
Radiation Oncology and Optometry Section of the Australian Government Department of 
Health (Health) contracted the Australian Institute of Health and Welfare (AIHW) to provide 
cancer incidence projections for all cancers combined (excluding basal cell and squamous cell 
carcinoma) at the national and jurisdictional health planning region levels (see Box 1).   
This report presents those projections for 2014 to 2024, based on cancer incidence trends from 
1997 to 2010.  
The data used in this report were supplied by the state and territory cancer registries to the 
National Cancer Statistics Clearing House and form the Australian Cancer Database. The 
methods and assumptions for these projections were developed by the AIHW in consultation 
with the state and territory cancer registries and Health. 
The state and territory cancer registries provided approvals to publish these estimates (see 
‘Summary—Important notes’). 
Box 1: Terminology used in this report 
Radiotherapy planning regions are referred to as health planning regions (HPRs) 
throughout the report. These regions are defined by geographical boundaries that may not 
reflect the total population accessing services (see Box 2). Each jurisdiction has a different 
name for these regions, as detailed in Chapter 2. 
Methods 
A number of models may be used for cancer incidence projections. These range from simple 
linear regression to multi-state analyses that attempt to account for changes in cancer 
incidence in response to changes in incidence of other diseases, such as diabetes and 
cardiovascular disease. Generally, more complex models will often provide a better fit of the 
historical data, but may provide a less robust predictive model if the pattern of interactions 
observed in the past does not continue into the future. There is a general consensus that a 
relatively simple linear or log-linear Poisson model of age-specific rates provides a good fit 
of the data while giving reasonably accurate predictions over a short to medium time span. 
Overview of projections method 
Generally, cancer projections are calculated by summing the projected incidence of each 
cancer type or grouping. However, the small area geography at which projected counts are 
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required for this project meant that the incidence of individual cancers would be too small in 
some cases for that method to be robust. Therefore, this project did not consider trends of 
individual cancers separately, instead modelling all cases of cancer together. The exception is 
prostate cancer, which was modelled separately to account for recent significantly 
fluctuating trends in prostate specific antigen (PSA) testing (see Figure A1). This method has 
been used in previous AIHW reports (AIHW 2012; AIHW 2013). 
The following four-step strategy was used to derive the projected incidence counts presented 
in this report: 
1. estimating the trend in annual incidence 
2. testing the significance of the trend 
3. extrapolating that trend to predict annual rates for the years 2014 to 2024 
4. applying those rates to projected populations to derive projected incidence counts by 
jurisdictional HPRs.  
These steps, summarised below, were applied separately to prostate cancer (males only) and 
all cancers (excluding prostate cancer) combined, and then summed for each jurisdiction’s 
HPRs. A more detailed description of the method—including the mathematical model and 
the prostate cancer-specific method—is available at appendix A. The data sources and 
populations used in deriving the estimates are available at Appendix B.  
Step 1—estimating the trend in annual incidence for 1997 to 2010 
The trend in annual cancer incidence was derived for each jurisdiction by sex and 5-year age 
group, using national cancer incidence data for the period 1997–2010. The exceptions are 
New South Wales and the Australian Capital Territory, where incidence data are available to 
2009 only. The trend estimation is based on the period 1997–2009 for these two jurisdictions.  
Step 2—testing the significance of the trend 
Each age–sex trend in each jurisdiction, derived in Step 1, was tested for significance, with 
one of three possible outcomes: a significant increasing trend, a significant decreasing trend 
or no significant trend. 
Step 3—predicting annual rates for 2014 to 2024 
The age–sex trends for each jurisdiction derived in Step 1 were linearly extrapolated to 
predict future annual rates, using one of three models—linear, logit or mean—applied 
according to the outcome of the significance testing in Step 2. 
• The linear model was applied to those age–sex groups with an increasing incidence, to 
avoid over-estimating future incidence as the rates are projected further forward in time. 
• The logit model was applied to those age–sex groups with decreasing incidence to avoid 
projecting incidence rates below zero. 
• The mean incidence rate was applied to those age–sex groups with a non–significant 
trend.  
Step 4—deriving projected incidence counts 
The projected rates, estimated in Step 3, were applied to Health projected populations by 
Statistical Local Area (SLA) (tables B3–B10) and summed to calculate projected counts for 
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each jurisdictional HPR. HPRs were defined using 2011 SLAs (online supplementary tables 
C1–C8). 
Limitations and assumptions 
It is important to note that the projections presented in this report are based on a number of 
assumptions relating to the estimation and extrapolation of trends in cancer incidence rates. 
The combined impact of these is such that the AIHW presents these projections only as 
approximate statistical extrapolations of the period 1997–2010, and can offer no guarantees 
as to their true predictive value out to 2014–2024. 
Projections of cancer rates and numbers are uncertain for a number of reasons: 
• uncertainties inherent in the fitted model that arise from the usual effects of random 
variation 
• assumptions that the trends of the past will continue into the future and that the chosen 
model is an adequate representation of those trends between populations and over time 
• uncertainties in projected populations. 
These sources of error are important and many of them cannot be readily quantified. 
Box 2: Limitations of using cancer incidence projections to determine future 
demand for radiation oncology services 
These projections are only for cancer incidence within geographically defined HPRs. They 
do not take into account the actual use of radiation oncology services within HPRs, 
including the use of services by residents of other states, territories or HPRs. 
For example, some residents of New South Wales use radiation oncology services within 
the Australian Capital Territory. The projected cancer incidence for the Australian Capital 
Territory will not take this additional demand for services into account.  
This means that cancer incidence projections alone are not a complete measure of future 
demand for radiation oncology services within each HPR. 
Uncertainties inherent in the fitted model 
Modelling cancer data to perform predictions of future trends is subject to both 
model-selection uncertainty and model-fitting instability. All models are subject to 
uncertainties, and while various models will often fit the historical data well for short time 
periods, projections arising from alternative models can be quite different. The accepted 
(conservative) approach among statisticians preparing projections of this nature is to assume 
a linear model for increasing rates, and a log-linear (logit transformation) model for 
decreasing rates. It should be noted, however, the trends for individual age groups used in 
these projections are not necessarily all in the same direction.  
 4 Radiation oncology areas of need: cancer incidence projections 2014–2024 
 
Assumptions regarding cancer trends 
It is important to note that the projections presented here should be treated with caution as 
they depend on a number of assumptions relating to trends in cancer incidence; namely that: 
• incidence rates for all cancers are homogeneous across all HPRs within each jurisdiction  
• the trends of the 14 years from 1997 to 2010 will continue for 2014 to 2024. 
Population projections 
Projected age-specific rates were used to calculate the number of future cancer cases for each 
HPR using projected population counts for that region; however, population projections are 
themselves subject to error due to assumptions of fertility, mortality and migration based on 
historical trends. Such trends may not reflect future effects on mortality through changing 
lifestyle factors such as decreases in smoking or increases in obesity. The Australian Bureau 
of Statistics (ABS) prepared the population projections used in this report specifically for 
Health planning purposes. They are not the official ABS projected populations. For more 
information on these populations, see Appendix B. 
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2  All cancer projections to 2024 
Since 1982, the first year for which national data are available, the number of new cancer 
cases diagnosed in Australia each year increased from around 47,400 in 1982 to more than 
116,500 in 2010, an increase of 146%. For comparison, during that same period, the 
Australian population increased from more than 15 million in 1982 to around 22 million in 
2010, an increase of 45%. 
This section provides the projected number of new cancer cases diagnosed for all cancers 
combined, in each jurisdictional HPR, from 2014 to 2024. 
National projections  
In 2024, an estimated 169,648 new cases of cancer are expected to be diagnosed in Australia, 
an average annual increase of 3.3% per year from 2010 (Table 2.1). The Australian population 
is expected to exceed 27 million by 2024, an increase of 1.8% per year from 2010. 
The proportional increase is expected to vary between states and territories: the largest 
increase is expected in Western Australia (5.0% per year), and the smallest in South Australia 
(1.9% per year). Note that these differences are due to differences between the population 
projections for each state and territory and/or the cancer incidence rate projections for each 
state and territory.  
Table 2.1: Incidence of all cancers combined, by jurisdiction: observed  
2010(a) and projected 2014 and 2024  
State/territory 2010(a) 2014 2024 
Average annual 
change (%)(b) 
NSW 38,279 41,918 52,428 2.5 
Vic 28,502 31,563 41,247 3.2 
Qld 23,453 27,325 37,348 4.2 
WA 11,231 13,032 19,104 5.0 
SA 9,219 9,772 11,722 1.9 
Tas 3,172 3,368 4,182 2.3 
ACT 1,524 1,969 2,541 4.4 
NT 697 841 1,075 3.9 
Australia 116,077 129,790 169,648 3.3 
(a) The actual counts presented for New South Wales and the Australian Capital Territory are for 2009,  
as actual data for these jurisdictions are not yet available for 2010. 
(b) The annual average percentage change is for 2024 compared with the last year of actual data  
available (2009 or 2010, see note (a)). 
Note: Projected jurisdictional estimates may not sum to the Australia total due to rounding. 
Source: Analysis of AIHW Australian Cancer Database 2010. 
  
 6 Radiation oncology areas of need: cancer incidence projections 2014–2024 
 
State and territory projections 
Cancer incidence projections from 2014 to 2024 by HPR are presented for each jurisdiction. 
Information on the construction of the HPRs, and any exceptions or exclusions, is detailed in 
the introductory text. The name given to the HPR-equivalent region in each jurisdiction is 
provided; however, the term HPR is used to refer to these regions thereafter.  
New South Wales 
New South Wales HPRs align with the state’s 16 Local Health Districts: Albury Wodonga 
Health, Central Coast, Far West, Hunter New England, Illawarra Shoalhaven, Mid North 
Coast, Murrumbidgee, Nepean Blue Mountains, Northern NSW, Northern Sydney, South 
Eastern Sydney, South Western Sydney, Southern NSW, Sydney, Western NSW, Western 
Sydney. 
A map showing the boundaries of these areas is available as supplementary material to this 
report, at <www.aihw.gov.au/cancer-publications/>. 
In 2011, 2 SLAs were split between HPRs. These were: 
• SLA 14600—Lachlan (A): 73.35% Western NSW and 26.65% Murrumbidgee  
• SLA 17400—Tenterfield (A): 91.84% Hunter New England and 8.16% Northern NSW. 
The concordance of SLAs to New South Wales HPRs is presented in online supplementary 
Table C1. See Table B3 for underlying projected populations for New South Wales HPRs. 
In 2024, an estimated 52,428 new cases of cancer are expected to be diagnosed in New South 
Wales, an annual average increase of 2.5% per year from 2009 (Table 2.1). Table 2.2 shows 
projected estimates by HPR. 
These projections were developed for national health planning purposes. For projections 
specific to New South Wales, see Cancer incidence and mortality projections: 2011–2021 (Cancer 
Institute NSW 2011).
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Table 2.2: Projected incidence of all cancers combined, by HPR, 2014 to 2024: New South Wales 
HPR 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 
1.   Albury Wodonga Health 296 303 311 319 328 336 344 353 362 371 380 
2.   Central Coast 2,135 2,162 2,190 2,219 2,245 2,271 2,296 2,322 2,352 2,378 2,403 
3.   Far West 214 219 224 229 234 239 244 248 254 259 264 
4.   Hunter New England 5,628 5,760 5,898 6,039 6,178 6,320 6,458 6,599 6,749 6,893 7,038 
5.   Illawarra Shoalhaven 2,540 2,597 2,654 2,713 2,771 2,831 2,890 2,949 3,011 3,072 3,133 
6.   Mid North Coast 1,570 1,598 1,627 1,657 1,685 1,713 1,741 1,769 1,800 1,829 1,856 
7.   Murrumbidgee 1,530 1,566 1,601 1,638 1,674 1,710 1,747 1,784 1,821 1,860 1,898 
8.   Nepean Blue Mountains 1,844 1,900 1,958 2,017 2,074 2,130 2,187 2,244 2,305 2,363 2,420 
9.   Northern NSW 2,094 2,137 2,179 2,223 2,266 2,309 2,353 2,396 2,442 2,487 2,530 
10. Northern Sydney 4,968 5,061 5,161 5,263 5,366 5,471 5,575 5,684 5,798 5,911 6,026 
11. South Eastern Sydney 4,662 4,757 4,857 4,956 5,058 5,162 5,267 5,378 5,493 5,609 5,728 
12. South Western Sydney 4,448 4,576 4,705 4,833 4,963 5,092 5,224 5,356 5,492 5,628 5,764 
13. Southern NSW 1,339 1,375 1,412 1,449 1,486 1,523 1,560 1,597 1,635 1,673 1,710 
14. Sydney 2,927 3,003 3,082 3,160 3,241 3,323 3,407 3,494 3,583 3,673 3,768 
15. Western NSW 1,702 1,745 1,791 1,837 1,881 1,925 1,971 2,017 2,065 2,111 2,157 
16. Western Sydney 4,022 4,145 4,273 4,402 4,532 4,665 4,797 4,935 5,073 5,214 5,354 
Total 41,918 42,905 43,921 44,954 45,982 47,020 48,062 49,125 50,234 51,330 52,428 
Note: Projected HPR estimates may not sum to the state total due to rounding. 
Source: Analysis of AIHW Australian Cancer Database 2010.
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Victoria 
Victoria HPRs align with the state’s 8 Integrated Cancer Service areas: Barwon South 
Western, Gippsland, Grampians, Hume, Loddon Mallee, North Eastern, Southern, Western 
Central. 
A map showing the boundaries of these areas is available as supplementary material to this 
report, at <www.aihw.gov.au/cancer-publications/>. 
The concordance of SLAs to Victoria HPRs, including 5 SLAs not assigned to an HPR, is 
presented in online supplementary Table C2. See Table B4 for underlying projected 
populations for Victoria HPRs. 
In 2024, an estimated 41,247 new cases of cancer are expected to be diagnosed in Victoria, an 
annual average increase of 3.2% per year from 2010 (Table 2.1). Table 2.3 shows projected 
estimates by HPR. 
These projections were developed for national health planning purposes. For projections 
specific to Victoria, see Cancer in Victoria: statistics and trends 2012 (Thursfield et al. 2013).
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Table 2.3: Projected incidence of all cancers combined, by HPR, 2014 to 2024: Victoria 
HPR 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 
1.  Barwon South Western 2,354 2,414 2,476 2,542 2,606 2,671 2,735 2,801 2,871 2,938 3,007 
2.  Gippsland 1,789 1,837 1,884 1,932 1,979 2,026 2,071 2,117 2,165 2,211 2,256 
3.  Grampians 1,417 1,457 1,499 1,542 1,584 1,626 1,669 1,711 1,756 1,799 1,844 
4.  Hume 1,728 1,777 1,828 1,878 1,928 1,978 2,029 2,081 2,134 2,185 2,236 
5.  Loddon Mallee 2,020 2,074 2,130 2,188 2,245 2,301 2,357 2,415 2,475 2,533 2,592 
6.  North Eastern 6,751 6,939 7,139 7,342 7,545 7,751 7,956 8,168 8,390 8,613 8,838 
7.  Southern 8,606 8,823 9,048 9,281 9,515 9,752 9,996 10,248 10,513 10,775 11,042 
8.  Western Central 6,892 7,113 7,345 7,582 7,821 8,070 8,325 8,590 8,863 9,138 9,427 
Ungrouped SLAs 5 5 5 5 5 5 5 5 5 5 5 
Total 31,563 32,439 33,352 34,292 35,229 36,181 37,144 38,136 39,171 40,198 41,247 
Note: Projected HPR estimates may not sum to the state total due to rounding. 
Source: Analysis of AIHW Australian Cancer Database 2010.
 10 Radiation oncology areas of need: cancer incidence projections 2014–2024 
 
Queensland 
Queensland HPRs align with the state’s 16 Hospital and Health Services areas: Cairns and 
Hinterland, Cape York, Central Queensland, Central West, Darling Downs, Gold Coast, 
Mackay, Metro North, Metro South, North West, South West, Sunshine Coast, Torres Strait—
Northern Peninsula, Townsville, West Moreton, Wide Bay. 
A map showing the boundaries of these areas is available as supplementary material to this 
report, at <www.aihw.gov.au/cancer-publications/>. 
In 2011, 2 SLAs were split between HPRs. These were: 
• SLA 32662 (Banana (S)): 95% Central Queensland and 5% Darling Downs 
• SLA 30370 (Cassowary Coast (R)—Cardwell): 80% Cairns and Hinterland and 20% 
Townsville. 
The concordance of SLAs to Queensland HPRs is presented in online supplementary 
Table C3. See Table B5 for underlying projected populations for Queensland HPRs. 
In 2024, an estimated 37,348 new cases of cancer are expected to be diagnosed in 
Queensland, an annual average increase of 4.2% per year from 2010 (Table 2.1). Table 2.4 
shows projected estimates by HPR. 
These projections were developed for national health planning purposes. For projections 
specific to Queensland, see Oncology Analysis System (OASys) (QCCAT 2014).
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Table 2.4: Projected incidence of all cancers combined, by HPR, 2014 to 2024: Queensland 
HPR 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 
1.   Cairns and Hinterland 1,428 1,489 1,552 1,616 1,681 1,747 1,814 1,880 1,947 2,014 2,084 
2.   Cape York 60 63 66 69 73 77 80 84 87 91 95 
3.   Central Queensland 1,137 1,187 1,238 1,290 1,343 1,397 1,451 1,506 1,562 1,619 1,679 
4.   Central West 78 80 81 83 85 87 89 91 92 94 96 
5.   Darling Downs 1,864 1,922 1,982 2,043 2,103 2,163 2,225 2,286 2,349 2,412 2,477 
6.   Gold Coast 3,447 3,564 3,686 3,811 3,937 4,066 4,194 4,327 4,462 4,597 4,738 
7.   Mackay 964 1,011 1,059 1,110 1,161 1,212 1,265 1,318 1,374 1,429 1,486 
8.   Metro North 5,168 5,322 5,481 5,647 5,814 5,981 6,150 6,321 6,497 6,674 6,856 
9.   Metro South 5,740 5,931 6,130 6,336 6,542 6,753 6,966 7,182 7,401 7,623 7,853 
10. North West 145 154 162 172 181 191 200 210 220 230 241 
11. South West 162 168 175 182 188 195 201 208 215 222 229 
12. Sunshine Coast 2,765 2,842 2,925 3,007 3,088 3,168 3,247 3,329 3,410 3,489 3,570 
13. Torres Strait—Northern Peninsula 32 33 34 36 37 38 39 41 42 44 45 
14. Townsville 1,311 1,365 1,423 1,482 1,541 1,600 1,659 1,722 1,786 1,850 1,915 
15. West Moreton 1,346 1,397 1,451 1,506 1,561 1,615 1,671 1,726 1,783 1,840 1,896 
16. Wide Bay 1,678 1,722 1,766 1,810 1,852 1,894 1,934 1,974 2,014 2,051 2,088 
Total 27,325 28,250 29,211 30,200 31,187 32,182 33,185 34,205 35,242 36,280 37,348 
Note: Projected HPR estimates may not sum to the state total due to rounding. 
Source: Analysis of AIHW Australian Cancer Database 2010.
 12 Radiation oncology areas of need: cancer incidence projections 2014–2024 
 
Western Australia 
Western Australia HPRs align with the state’s 9 Health Region areas: Goldfields, Great 
Southern, Kimberley, Midwest, North Metro, Pilbara, South Metro, South West, Wheatbelt. 
A map showing the boundaries of these areas is available as supplementary material to this 
report, at <www.aihw.gov.au/cancer-publications/>. 
The concordance of SLAs to Western Australia HPRs is presented in online supplementary 
Table C4. See Table B6 for underlying projected populations for Western Australia HPRs. 
In 2024, an estimated 19,104 new cases of cancer are expected to be diagnosed in Western 
Australia, an annual average increase of 5.0% per year from 2010 (Table 2.1). Table 2.5 shows 
projected estimates by HPR. 
These projections were developed for national health planning purposes. For projections 
specific to Western Australia, see Cancer incidence and mortality in Western Australia, 2009 
(Threlfall & Thompson 2010).
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Table 2.5: Projected incidence of all cancers combined, by HPR, 2014 to 2024: Western Australia 
HPR 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 
1.  Goldfields 256 271 287 304 321 339 356 374 393 412 432 
2.  Great Southern 396 410 425 440 455 469 484 499 513 528 543 
3.  Kimberley 141 151 162 173 184 196 207 220 233 247 260 
4.  Midwest 378 393 409 425 441 457 473 489 506 523 540 
5.  North Metro 5,314 5,529 5,757 5,995 6,235 6,480 6,729 6,987 7,256 7,529 7,809 
6.  Pilbara 208 227 247 269 291 313 337 362 388 415 443 
7.  South Metro 4,871 5,060 5,257 5,461 5,666 5,877 6,090 6,311 6,539 6,771 7,010 
8.  South West 967 1,008 1,051 1,093 1,136 1,180 1,223 1,269 1,315 1,360 1,406 
9.  Wheatbelt 501 516 532 549 566 582 597 613 630 646 661 
Total 13,032 13,566 14,127 14,708 15,294 15,892 16,497 17,125 17,774 18,431 19,104 
Note: Projected HPR estimates may not sum to the state total due to rounding. 
Source: Analysis of AIHW Australian Cancer Database 2010.
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South Australia 
South Australia HPRs align with the state’s 4 Local Hospital Network areas: Central 
Adelaide, Country Health SA, Northern Adelaide, Southern Adelaide. 
A map showing the boundaries of these areas is available as supplementary material to this 
report, at <www.aihw.gov.au/cancer-publications/>. 
The concordance of SLAs to South Australia HPRs is presented in online supplementary 
Table C5. See Table B7 for underlying projected populations for South Australia HPRs. 
In 2024, an estimated 11,722 new cases of cancer are expected to be diagnosed in South 
Australia, an annual average increase of 1.9% per year from 2010 (Table 2.1). Table 2.6 shows 
projected estimates by HPR. 
These projections were developed for national health planning purposes. For information on 
cancer incidence specific to South Australia, see Cancer in South Australia 2009—with 
projections to 2012 (South Australian Cancer Registry 2013).
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Table 2.6: Projected incidence of all cancers combined, by HPR, 2014 to 2024: South Australia 
HPR 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 
1.  Central Adelaide 2,880 2,915 2,952 2,990 3,027 3,069 3,111 3,155 3,205 3,254 3,304 
2.  Country Health SA 3,070 3,136 3,203 3,269 3,335 3,401 3,467 3,534 3,604 3,670 3,736 
3.  Northern Adelaide 1,733 1,776 1,821 1,867 1,911 1,956 2,001 2,047 2,096 2,143 2,190 
4.  Southern Adelaide 2,089 2,124 2,161 2,200 2,239 2,279 2,320 2,361 2,406 2,449 2,492 
Total 9,772 9,952 10,137 10,325 10,513 10,704 10,899 11,096 11,311 11,516 11,722 
Note: Projected HPR estimates may not sum to the state total due to rounding. 
Source: Analysis of AIHW Australian Cancer Database 2010.
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Tasmania 
Tasmania HPRs align with the state’s 3 Health Region areas: North West, Northern, 
Southern. 
A map showing the boundaries of these areas is available as supplementary material to this 
report, at <www.aihw.gov.au/cancer-publications/>. 
The concordance of SLAs to Tasmania HPRs is presented in online supplementary Table C6. 
See Table B8 for underlying projected populations for Tasmania HPRs. 
In 2024, an estimated 4,182 new cases of cancer are expected to be diagnosed in Tasmania, an 
annual average increase of 2.3% per year from 2010 (Table 2.1). Table 2.7 shows projected 
estimates by HPR.  
These projections were developed for national health planning purposes. For information on 
cancer incidence specific to Tasmania, see Cancer in Tasmania: incidence and mortality 2010 
(Stokes et al. 2013).
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Table 2.7: Projected incidence of all cancers combined, by HPR, 2014 to 2024: Tasmania 
HPR 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 
1.  North West 774 790 808 824 841 857 874 890 906 922 937 
2.  Northern 959 981 1,003 1,026 1,048 1,071 1,093 1,115 1,138 1,160 1,183 
3.  Southern 1,635 1,677 1,720 1,764 1,808 1,850 1,891 1,934 1,976 2,018 2,061 
Total 3,368 3,448 3,531 3,615 3,697 3,778 3,858 3,939 4,020 4,100 4,182 
Note: Projected HPR estimates may not sum to the state total due to rounding. 
Source: Analysis of AIHW Australian Cancer Database 2010.
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Australian Capital Territory 
The Australian Capital Territory is considered a single HPR. A map of the Australian Capital 
Territory HPR is available as supplementary material to this report, at 
<www.aihw.gov.au/cancer-publications/>. 
See Table B9 for underlying projected populations for the Australian Capital Territory. 
In 2024, an estimated 2,541 new cases of cancer are expected to be diagnosed in the 
Australian Capital Territory, an annual average increase of 4.4% per year from 2009 
(Table 2.1). These data are also shown in Table 2.8. 
These projections were developed for national health planning purposes. For information on 
cancer incidence specific to the Australian Capital Territory, see Cancer in the ACT: incidence 
and mortality 2011 (ACT Health 2011). 
Table 2.8: Projected incidence of all cancers combined, by HPR, 2014 to 2024: Australian Capital 
Territory 
HPR 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 
Total 1,969 2,026 2,084 2,145 2,203 2,260 2,317 2,373 2,429 2,485 2,541 
Source: Analysis of AIHW Australian Cancer Database 2010. 
Northern Territory 
The Northern Territory is considered a single HPR. A map of the Northern Territory HPR is 
available as supplementary material to this report, at <www.aihw.gov.au/cancer-
publications/>. 
See Table B10 for underlying projected populations for the Northern Territory. 
In 2024, an estimated 1,075 new cases of cancer are expected to be diagnosed in the Northern 
Territory, an annual average increase of 3.9% per year from 2010 (Table 2.1). These data are 
also shown below in Table 2.9.  
These projections were developed for national health planning purposes. For information on 
cancer incidence specific to the Northern Territory, see Cancer in the Northern Territory 1991–
2010: incidence, mortality and survival (Zhang et al. 2014). 
Table 2.9: Projected incidence of all cancers combined, by HPR, 2014 to 2024: Northern Territory 
HPR 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 
Total 841 867 895 921 945 968 991 1,013 1,034 1,054 1,075 
Source: Analysis of AIHW Australian Cancer Database 2010. 
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Appendix A Statistical methods 
Modelling jurisdictional trends to HPRs 
State and territory level projections for all cancers combined include projections for 
individual HPRs. Past trends for cancer incidence in small geographic areas are of limited 
value as estimators of future trends because they are imprecise, due to the small number of 
cancer cases in any specific area. For example, if a specific HPR had a trend of decline or 
increase that was significantly different for the state or territory, it would be unclear whether 
this reflected a real difference or a random fluctuation. This is a critical problem because 
even small changes in the trend can cause large changes in projected numbers. The strategy 
used by Coorey and Armstrong (1998) and adapted in this study was to obtain projections 
for each HPR using projected rates for the whole state or territory applied to small 
area-specific population projections. This provides sufficient data to provide statistical 
stability while retaining state and territory level variations from the national data. 
The projected rates for each state or territory were obtained by extrapolating past trends for 
all cancers (except prostate cancer) combined and prostate cancer separately using 
age-period interaction models. The historical trend data were taken from 1997 to 2010, with 
the exception of New South Wales and the Australian Capital Territory where the period 
1997 to 2009 was used (Table A1).  
The prostate cancer method differs slightly from that for all cancers combined. Projected 
rates were predicted using observed incidence counts for the years 1997 to 2010 and 
estimated counts for 2011 to 2013; these estimates were obtained by regressing annual 
incidence for 2002 to 2010 against the corresponding number of PSA tests (see ‘Special case of 
prostate cancer incidence trends’ below).  
The choice of age groups is a compromise between accurate fitting of the data and precision 
of the model parameters. While a greater number of age groups provides more accurate 
fitting of the data, precision of model parameters falls with the reduced number of cases in 
each group. The age groups for modelling each jurisdiction were the standard 5-year age 
groups. Exceptions to this were those jurisdictions where there were zero (0) cases in some  
5-year age groups. To overcome this problem and maintain statistical integrity, some age 
groups were combined (Table A1).  
Table A1: Input variables to projections model, by state and territory 
State/territory First year Final year Age groups 
New South Wales 1997 2009 0–4, 5–9, …, 75–79, 85+ 
Victoria 1997 2010 0–4, 5–9, …, 75–79, 85+ 
Queensland 1997 2010 0–4, 5–9, …, 75–79, 85+ 
Western Australia 1997 2010 0–4, 5–9, …, 75–79, 85+ 
South Australia 1997 2010 0–4, 5–9, …, 75–79, 85+ 
Tasmania 1997 2010 0–14, 15–19, 20–24, 25–29, …, 75–79, 85+ 
Australian Capital Territory 1997 2009 0–14, 15–24, 25–29, 30–34, …, 75–79, 85+ 
Northern Territory 1997 2010 0–14, 15–24, 25–29, 30–34, …, 75–79, 85+ 
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For prostate cancer, broader age groups were selected (0–44, 45–54, 55–64, 65–74, 75–84 and 
85 and over), and applied to all jurisdictions. 
For each age–sex combination, a simple linear model—with time as the explanatory 
variable—was estimated for the incidence rate using ordinary least squares. This effectively 
fits a separate linear model to each age group by sex cross-classification and assumes that the 
incidence rate within each age–sex cross-classification changes by a fixed quantity each year.  
Parameter estimation was carried out in SAS using PROC REG. The significance of time as a 
predictor was determined at the 5% level by applying a two-tailed test to its coefficient. The 
model selected was dependent on the significance and direction of each age–sex trend:  
• A linear regression model was used for significant increasing trends. 
• A logit transformation was used for significant decreasing trends.  
• The mean was used for non-significant trends.  
The appropriate model was fitted to past age–sex cancer incidence data and used to project 
future incidence rates for 2014 to 2024. A mathematical form of the model is shown in 
Box A1. 
Confidence, projection or sensitivity intervals were not calculated for the projected incidence 
counts presented in this report. The calculation of such intervals is not recommended 
practice when the projected data are used for administrative or planning purposes (Moller et 
al. 2005). 
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Box A1: Statistical projection model  
Let  
 ia  = the incidence rate in age–sex cell i for the whole state or territory 
 ib  = the increment rate in age–sex cell i for the whole state or territory 
 t  = year 
 itR = the modelled age–sex specific incidence rate for age–sex cell I and year t 
 itn  = the population count in age–sex cell i for year t in the SLA 
 ite  = the expected number of cancer cases in age–sex cell i for year t in the SLA 
 
Then the modelled rate for age–sex cell i in the whole state or territory is given by 
 tbaR iiit +=    for increasing trends 
or 
 logit ( ) tbaR iiit +=   for decreasing trends. 
 
That is,   
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and the expected number of cancer cases in each HPR for year t is given by  
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Special case of prostate cancer incidence trends 
The incidence of all cancers combined is increasing over time. This does not account for 
variations in specific cancers, which may be affected by a number of factors including 
lifestyle changes, screening and early detection. This effect is particularly evident for prostate 
cancer, following the introduction of PSA testing.  
Prostate cancer accounts for around 30% of all new cancers diagnosed in males (excluding 
non-melanoma skin cancers). Age-standardised incidence rates of prostate cancer in 
Australia have undergone a number of fluctuations since national data were first collected in 
1982. 
Between 1982 and 2009, there was an overall 144% increase in the incidence of prostate 
cancer (Figure A1). This increase occurred in four broad phases, with some annual 
fluctuation, in which age-standardised prostate cancer incidence rates: 
• were steady between 1982 and 1988, at around 82 new cases per 100,000 males 
• increased sharply from 86 per 100,000 in 1988 to 184 per 100,000 in 1994, followed by a 
sharp decline to 130 per 100,000 in 1997 
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• were steady between 1997 and 2001, at around 130 new cases per 100,000 males 
• increased from 136 per 100,000 in 2002 to 194 per 100,000 in 2009 (AIHW 2013). 
 
Note: Rates are directly age-standardised to the Australian population as at 30 June 2001 and expressed per 100,000 males. 
Source: AIHW Australian Cancer Database 2009; Figure 3.2 in AIHW 2013. 
Figure A1: Prostate cancer incidence among males, Australia, 1982 to 2009 
Some of this variation in prostate cancer incidence is attributed to PSA testing for the 
detection of asymptomatic prostate cancer. 
PSA is a protein produced within the prostate and is quantifiable by a blood test (PSA test). 
PSA levels in the blood naturally increase with increasing age, and a PSA level that is higher 
than ‘normal’ for that age can be an indicator of risk of prostate cancer (AIHW 2013). 
In Australia, the PSA test was introduced in 1987 and first included on the Medicare Benefits 
Schedule (MBS) in 1989. This is thought to have contributed to the peak in prostate cancer 
incidence during the early 1990s by uncovering a large pool of asymptomatic cases 
(Figure A1). Many of those cases may have remained undiagnosed until symptoms 
developed years later (AIHW & AACR 2010a). The PSA threshold at which a male is referred 
for a prostate biopsy was lowered in 2002 (Smith et al. 2008). This procedural change is 
thought to have contributed to the second increase in prostate cancer incidence—observed 
from 2002 (Figure A1)—by uncovering another pool of prostate cancer cases that may 
otherwise have remained undetected for many years. Many of these males would previously 
have been considered ‘lower risk’. The resulting upward trend in incidence was similar to 
that for the early 1990s. 
The volatile fluctuation of age-standardised incidence rates for prostate cancer makes it 
difficult to predict future incidence trends. While data are available for most states and 
territories for 2010, data are not available for New South Wales or the Australian Capital 
Territory. Available state and territory incidence data for 2010 show that prostate cancer 
incidence has started to decrease, suggesting a similar downward trend to that seen in 1997. 
However, without actual incidence data from New South Wales and the Australian Capital 
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Territory, it is not possible to confirm either that this change in trend is occurring nationally, 
or to what degree the downward turn will continue.  
Because of this uncertainty, projections for prostate cancer have been modelled separately to 
all other cancers combined and the results from each model summed to provide projections 
for all cancers. The method for the prostate cancer model uses current MBS data on PSA 
testing to assess: 
1. the trend in PSA testing 
2. the relationship between prostate cancer incidence and PSA testing (incidence: PSA test 
ratio). 
These data are then used to estimate prostate cancer incidence from 2011 to 2013 and, 
combined with historical data from 1997 to 2010, provide a more robust model from which to 
project incidence to 2024. Note that, similar to the model for all other cancers combined, the 
model for New South Wales and the Australian Capital Territory is based on actual prostate 
cancer incidence data from 1997 to 2009, and inferred incidence data from 2010 to 2013. 
MBS Item 66655, allowing a single test for ‘prostate specific antigen, quantitation’ in each 12-
month period, has been listed on the MBS since May 2001. For the purpose of this report, 
data from 1 January 2002 to 31 December 2010 were used to quantify the relationship 
between PSA testing and prostate cancer incidence, by broad age groups  
(0–44, 45–54, 55–64, 65–74, 75–84, 85 and over) for each state and territory.  
The observed ratios were regressed using the method shown in Box A1 and the resulting 
model (significant increasing, significant decreasing or mean) for each age group was used to 
estimate the ratio for years 2011 to 2013. These ratios were applied to PSA test data for 
1 January 2011 to 31 December 2013 and used to estimate prostate cancer incidence for those 
years. 
The estimated incidence data for prostate cancer for the period 2011–2013 were added to 
those actual data for 1997–2010, and projected counts for prostate cancer for 2014 to 2024 
were calculated as per the model for all cancers combined (Box A1). Note that for New South 
Wales and the Australian Capital Territory—similar to the model for all other cancers 
combined—estimated (inferred) prostate cancer incidence data for 2010–2013 were added to 
the actual data for 1997–2009. 
It is important to note that if the actual prostate cancer incidence data for New South Wales 
and the Australian Capital Territory for 2010, when available, differ substantially from the 
inferred incidence derived by the method above, it would be prudent to revise the 
projections for these jurisdictions. 
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Appendix B Data sources and 
classifications 
Australian Cancer Database 
The Australian Cancer Database contains information on Australians who were diagnosed 
with cancer (excluding basal cell and squamous cell carcinomas of the skin) between 1982 
and 2010. Data are collected by state and territory cancer registries from a number of sources 
and are supplied annually to the AIHW. The AIHW compiles and maintains the Australian 
Cancer Database, in partnership with the Australasian Association of Cancer Registries. In 
Australia, cancer is a notifiable disease. This means that reporting all cancers (excluding 
basal cell and squamous cell carcinomas of the skin) is mandatory under legislation in each 
Australian state and territory. 
Cancer reporting and registration is a dynamic process, and records in the state and territory 
cancer registries may be modified if new information is received. As a result, the number of 
cancer cases reported by the AIHW for any particular year may change slightly over time 
and may not always align with state and territory reporting for that same year (AIHW & 
AACR 2010b).  
The most recent year of national cancer incidence data currently available in the Australian 
Cancer Database is 2010. The 2010 incidence data are based on actual incidence data for all 
states and territories except New South Wales and the Australian Capital Territory, where 
actual incidence data are available up to 2009.   
The Data Quality Statement for the Australian Cancer Database 2010 can be found on the 
AIHW website at <http://meteor.aihw.gov.au/content/index.phtml/itemId/565218>. 
A review of the Australian Cancer Database collection is in progress and this report will be 
published on the AIHW website in 2014. 
Medicare Benefits Schedule 
The MBS database records the number of tests and demographic information on the 
recipients of those tests. Medicare claims data, used to derive trends in PSA testing based on 
‘Item 66655—prostate specific antigen, quantitation’ for the period 1 January 2002 to 
31 December 2013, were sourced from the Medicare Australia website, 
<https://www.medicareaustralia.gov.au/statistics/mbs_item.shtml>. 
A summary of claims, by state and territory and years, is presented in Table B1. 
  Radiation oncology areas of need: cancer incidence projections 2014–2024 25 
Table B1: MBS claims for Item 66655, by state and territory,  
2002, 2013 and 2002–2013 
State/territory 2002 2013 2002–2013 
NSW 153,282 216,472 2,753,029 
Vic 103,344 185,444 2,313,650 
Qld 96,910 159,025 1,685,623 
WA 62,080 72,366 945,948 
SA 48,586 59,617 792,131 
Tas 12,697 10,795 212,323 
ACT 10,484 8,669 140,014 
NT 3,228 3,971 53,540 
Australia 490,611 716,359 8,896,258 
Source: Medicare Australia 2014. 
These data include only those services performed by a registered provider of services that 
qualify for Medicare Benefit and for which a claim was processed by Medicare Australia. 
They do not include services provided by hospital doctors to public patients in public 
hospitals or services that qualify for a benefit under the Department of Veterans’ Affairs 
National Treatment Account. The state or territory is determined according to the address (at 
the time of claiming) of the patient to whom the service was rendered.  
Population data 
Two distinct sources of population data are used in this report: historical populations and 
projected populations. 
Historical population data 
Historical populations for 1997 to 2013, used to derive the age-specific incidence rates, were 
sourced from the ABS. The populations used in this report are the 30 June rebased 
populations derived from the 2011 Census of Population and Housing. Note that while the 
populations for 1997 to 2011 are final, those for 2012 and 2013 are preliminary. 
Populations are updated over time, and those used in this report are summarised in Table B2 
for information. They are also available from the ABS website, 
<http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3101.0Jun%202013?OpenDoc
ument >. 
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Table B2: Rebased estimated resident population, by state and territory, 1997 to 2010 (30 June) 
Year NSW Vic Qld WA SA Tas ACT NT Australia 
1997 6,246,267 4,569,297 3,355,417 1,798,341 1,475,658 474,908 310,533 189,755 18,420,176 
1998 6,305,799 4,606,970 3,404,484 1,826,440 1,483,270 473,430 311,532 192,905 18,604,830 
1999 6,375,103 4,652,462 3,453,936 1,853,936 1,490,934 473,030 314,171 196,012 18,809,584 
2000 6,446,558 4,704,065 3,509,458 1,879,093 1,497,503 473,123 317,235 199,149 19,026,184 
2001 6,530,349 4,763,615 3,571,469 1,906,274 1,503,461 473,668 321,538 201,743 19,272,117 
2002 6,580,807 4,817,774 3,653,123 1,928,512 1,511,567 474,152 324,627 202,251 19,492,813 
2003 6,620,715 4,873,809 3,743,121 1,952,741 1,520,399 478,534 327,357 201,725 19,718,401 
2004 6,650,735 4,927,149 3,829,970 1,979,542 1,528,189 483,178 328,940 202,663 19,930,366 
2005 6,693,206 4,989,246 3,918,494 2,011,207 1,538,804 486,202 331,399 205,905 20,174,463 
2006 6,742,690 5,061,266 4,007,992 2,050,581 1,552,529 489,302 335,170 209,057 20,448,587 
2007 6,834,156 5,153,522 4,111,018 2,106,139 1,570,619 493,262 342,644 213,748 20,825,108 
2008 6,943,461 5,256,375 4,219,505 2,171,700 1,588,665 498,568 348,368 219,874 21,246,516 
2009 7,053,755 5,371,934 4,328,771 2,240,250 1,608,902 504,353 354,785 226,027 21,688,777 
2010 7,144,292 5,461,101 4,404,744 2,290,845 1,627,322 508,847 361,766 229,778 22,028,695 
2011 7,218,529 5,537,817 4,476,778 2,353,409 1,639,614 511,483 367,985 231,292 22,336,907 
2012 7,305,530 5,631,567 4,568,695 2,436,179 1,656,274 512,190 375,117 235,206 22,720,758 
2013 7,407,682 5,737,615 4,658,557 2,517,165 1,670,834 513,012 383,375 239,507 23,127,747 
Note: While populations for 1997 to 2011 are final, those for 2012 and 2013 are preliminary. 
Source: ABS rebased 30 June estimated resident population. 
Projected population data (preliminary) 
Preliminary projected populations by SLA for 2014 to 2024, used to derive the projected 
incidence counts by jurisdictional HPR, were prepared by the ABS as consultant to Health to 
inform statistics on ageing and aged care. 
The projected populations used in this report are based on preliminary 2011 Census-based 
estimated resident populations, projected forward to 2026. The assumptions used to derive 
these projections are consistent with the ABS Series B projections, and reflect moderate 
assumptions of births, deaths and migration. The underlying geography for these 
preliminary projections is the Australian Standard Geographical Classification SLA.  
It is important to note that the projections used in this report are not official ABS data and 
differ from projected populations published elsewhere. The differences can be attributed to 
methodology, geography (Australian Standard Geographical Classification, not Australian 
Standard Geographical Standard) and status (preliminary, not final). Caution is advised 
when comparing the projections presented in this report with other incidence projections, 
taking into consideration the underlying populations. Tables B3–B10 present a summary of 
the preliminary population projections used in this report for each jurisdiction. 
The final version of these projections, based on the Australian Statistical Geography 
Standard geography (SA2), will be available on the Health website from mid-2014 
<http://www.health.gov.au/internet/main/publishing.nsf/Content/ageing–stats–
lapp.htm>.
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Table B3: Preliminary projected populations by HPR, 2014 to 2024: New South Wales 
HPR 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 
1.   Albury Wodonga Health 51,101 51,660 52,221 52,780 53,335 53,878 54,405 54,925 55,428 55,917 56,388 
2.   Central Coast 329,998 333,376 336,960 340,551 344,144 347,746 351,362 355,093 358,947 362,931 367,048 
3.   Far West 32,057 32,351 32,640 32,922 33,196 33,463 33,721 33,977 34,226 34,469 34,707 
4.   Hunter New England 890,726 898,590 906,450 914,169 921,757 929,175 936,386 943,408 950,219 956,805 963,179 
5.   Illawarra Shoalhaven 394,505 398,000 401,480 404,913 408,275 411,594 414,811 417,959 421,026 424,011 426,896 
6.   Mid North Coast 211,341 212,698 214,059 215,397 216,718 218,016 219,313 220,588 221,854 223,107 224,352 
7.   Murrumbidgee 241,894 244,195 246,547 248,872 251,173 253,429 255,653 257,854 260,014 262,155 264,256 
8.   Nepean Blue Mountains 362,467 367,863 373,441 378,960 384,408 389,795 395,123 400,488 405,889 411,339 416,830 
9.   Northern NSW 301,130 303,266 305,326 307,343 309,319 311,256 313,172 315,064 316,919 318,751 320,557 
10. Northern Sydney 878,772 888,735 899,012 909,031 918,822 928,401 937,795 947,304 956,913 966,644 976,503 
11. South Eastern Sydney 878,091 889,970 902,270 914,349 926,198 937,763 949,009 960,218 971,367 982,427 993,343 
12. South Western Sydney 914,141 928,598 943,500 958,267 972,885 987,367 1,001,670 1,016,073 1,030,599 1,045,292 1,060,115 
13. Southern NSW 201,536 203,278 204,988 206,651 208,253 209,832 211,377 212,879 214,334 215,754 217,133 
14. Sydney 608,831 618,726 628,824 638,690 648,303 657,596 666,543 675,310 683,886 692,266 700,426 
15. Western NSW 282,902 286,147 289,316 292,441 295,524 298,543 301,526 304,447 307,321 310,154 312,947 
16. Western Sydney 882,953 896,376 910,061 923,447 936,505 949,205 961,534 973,759 985,880 997,930 1,009,911 
Total 7,462,445 7,553,829 7,647,095 7,738,783 7,828,815 7,917,059 8,003,400 8,089,346 8,174,822 8,259,952 8,344,591 
Source: Department of Health 2013. 
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Table B4: Preliminary projected populations by HPR, 2014 to 2024: Victoria 
HPR 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 
1.  Barwon South Western 378,434 382,740 387,044 391,287 395,462 399,558 403,564 407,489 411,331 415,090 418,762 
2.  Gippsland 267,134 270,074 273,005 275,872 278,681 281,431 284,119 286,744 289,292 291,778 294,194 
3.  Grampians 231,192 233,897 236,611 239,285 241,928 244,527 247,079 249,586 252,056 254,487 256,874 
4.  Hume 275,352 278,600 281,830 285,016 288,149 291,234 294,264 297,243 300,187 303,085 305,943 
5.  Loddon Mallee 318,606 322,212 325,826 329,407 332,954 336,446 339,878 343,279 346,631 349,939 353,180 
6.  North Eastern 1,250,285 1,282,159 1,315,846 1,348,361 1,379,682 1,409,801 1,438,662 1,467,785 1,497,190 1,526,913 1,556,947 
7.  Southern 1,592,848 1,618,713 1,644,700 1,670,845 1,697,112 1,723,505 1,749,977 1,776,424 1,802,830 1,829,230 1,855,578 
8.  Western Central 1,508,216 1,537,183 1,566,247 1,595,376 1,624,521 1,653,605 1,682,576 1,711,335 1,739,875 1,768,200 1,796,260 
Ungrouped SLAs 746 746 746 746 746 746 746 746 746 746 746 
Total 5,822,813 5,926,324 6,031,855 6,136,195 6,239,235 6,340,853 6,440,865 6,540,631 6,640,138 6,739,468 6,838,484 
Source: Department of Health 2013. 
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Table B5: Preliminary projected populations by HPR, 2014 to 2024: Queensland 
HPR 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 
1.   Cairns and Hinterland 247,394 252,899 258,501 264,041 269,527 274,939 280,273 285,567 290,830 296,059 301,275 
2.   Cape York 15,578 15,968 16,361 16,751 17,137 17,517 17,891 18,268 18,648 19,028 19,407 
3.   Central Queensland 211,154 215,907 220,823 225,690 230,508 235,266 239,948 244,596 249,215 253,819 258,409 
4.   Central West 13,017 13,229 13,436 13,645 13,851 14,061 14,267 14,469 14,667 14,869 15,068 
5.   Darling Downs 299,162 305,679 312,163 318,625 325,028 331,385 337,710 344,023 350,358 356,713 363,068 
6.   Gold Coast 559,655 570,650 581,733 592,714 603,559 614,285 624,847 635,340 645,727 656,043 666,238 
7.   Mackay 183,939 188,202 192,495 196,723 200,886 204,997 209,020 212,992 216,917 220,800 224,657 
8.   Metro North 940,322 958,796 977,717 996,420 1,014,984 1,033,274 1,051,364 1,069,465 1,087,623 1,105,803 1,123,995 
9.   Metro South 1,099,235 1,123,092 1,147,461 1,171,542 1,195,338 1,218,863 1,242,002 1,265,109 1,288,161 1,311,223 1,334,241 
10. North West 35,369 36,415 37,462 38,497 39,523 40,535 41,532 42,521 43,497 44,462 45,425 
11. South West 28,628 29,341 30,059 30,771 31,471 32,165 32,855 33,546 34,232 34,922 35,612 
12. Sunshine Coast 382,751 389,341 395,996 402,586 409,119 415,575 421,966 428,348 434,728 441,108 447,489 
13. Torres Strait—Northern Peninsula 11,466 11,682 11,901 12,118 12,338 12,557 12,775 12,993 13,211 13,434 13,655 
14. Townsville 254,646 260,566 266,502 272,383 278,228 283,991 289,702 295,387 301,040 306,651 312,230 
15. West Moreton 260,928 267,222 273,539 279,865 286,058 292,180 298,220 304,239 310,234 316,229 322,228 
16. Wide Bay 216,170 219,960 223,807 227,622 231,399 235,145 238,834 242,529 246,215 249,895 253,572 
Total 4,759,414 4,858,949 4,959,956 5,059,993 5,158,954 5,256,735 5,353,206 5,449,392 5,545,303 5,641,058 5,736,569 
Source: Department of Health 2013. 
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Table B6: Preliminary projected populations by HPR, 2014 to 2024: Western Australia 
HPR 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 
1.  Goldfields 62,448 64,209 65,982 67,737 69,466 71,172 72,863 74,536 76,197 77,843 79,473 
2.  Great Southern 62,928 64,240 65,571 66,891 68,200 69,500 70,784 72,067 73,349 74,629 75,908 
3.  Kimberley 40,588 41,579 42,577 43,571 44,553 45,523 46,477 47,426 48,365 49,297 50,220 
4.  Midwest 69,745 71,284 72,840 74,386 75,917 77,439 78,941 80,445 81,945 83,445 84,934 
5.  North Metro 1,065,560 1,099,715 1,134,835 1,169,655 1,204,131 1,238,197 1,271,803 1,305,544 1,339,394 1,373,364 1,407,425 
6.  Pilbara 67,898 69,609 71,302 72,972 74,604 76,202 77,766 79,297 80,792 82,255 83,686 
7.  South Metro 952,666 982,763 1,013,659 1,044,295 1,074,650 1,104,673 1,134,328 1,164,051 1,193,832 1,223,681 1,253,575 
8.  South West 169,762 173,554 177,388 181,187 184,941 188,663 192,328 195,994 199,653 203,289 206,909 
9.  Wheatbelt 78,861 80,128 81,413 82,690 83,959 85,208 86,457 87,695 88,924 90,152 91,375 
Total 2,570,456 2,647,081 2,725,567 2,803,384 2,880,421 2,956,577 3,031,747 3,107,055 3,182,451 3,257,955 3,333,505 
Source: Department of Health 2013. 
 
Table B7: Preliminary projected populations by HPR, 2014 to 2024: South Australia 
HPR 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 
1.  Central Adelaide 489,315 493,972 498,816 503,577 508,231 512,782 517,211 521,617 525,985 530,294 534,522 
2.  Country Health SA 491,351 496,193 501,036 505,786 510,441 514,995 519,446 523,826 528,125 532,349 536,495 
3.  Northern Adelaide 348,886 354,331 359,858 365,274 370,568 375,726 380,749 385,705 390,613 395,474 400,312 
4.  Southern Adelaide 360,323 364,125 368,037 371,869 375,634 379,319 382,901 386,484 390,053 393,640 397,213 
Total 1,689,875 1,708,621 1,727,747 1,746,506 1,764,874 1,782,822 1,800,307 1,817,632 1,834,776 1,851,757 1,868,542 
Source: Department of Health 2013. 
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Table B8: Preliminary projected populations by HPR, 2014 to 2024: Tasmania 
HPR 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 
1.  North West 115,670 116,133 116,587 117,012 117,412 117,789 118,145 118,469 118,770 119,045 119,296 
2.  Northern 144,902 145,510 146,106 146,667 147,183 147,659 148,090 148,482 148,823 149,129 149,382 
3.  Southern 260,180 262,336 264,496 266,606 268,667 270,660 272,578 274,453 276,279 278,049 279,772 
Total 520,752 523,979 527,189 530,285 533,262 536,108 538,813 541,404 543,872 546,223 548,450 
Source: Department of Health 2013. 
 
Table B9: Preliminary projected populations, 2014 to 2024: Australian Capital Territory 
HPR 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 
Australian Capital Territory 387,037 393,801 400,660 407,445 414,151 420,768 427,285 433,772 440,233 446,674 453,084 
Source: Department of Health 2013. 
 
Table B10: Preliminary projected populations, 2014 to 2024: Northern Territory 
HPR 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 
Northern Territory 240,151 243,146 246,147 249,148 252,023 254,945 257,718 260,503 263,311 266,035 268,844 
Source: Department of Health 2013.
 32 Radiation oncology areas of need: cancer incidence projections 2014–2024 
 
References 
ACT Health 2011. Cancer in the ACT: incidence and mortality 2011. Health series no. 56. 
Canberra: ACT Health. 
AIHW (Australian Institute of Health and Welfare) 2012. Cancer incidence projections: 
Australia, 2011 to 2020. Cancer series no. 66. Cat. no. CAN 62. Canberra: AIHW. 
AIHW 2013. Prostate cancer in Australia. Cancer series no. 79. Cat. no. CAN 76. Canberra: 
AIHW. 
AIHW & AACR 2010a. Cancer in Australia 2010: an overview. Cancer series no. 60. Cat. no. 
CAN 56. Canberra: AIHW. 
AIHW & AACR 2010b. National Cancer Statistics Clearing House protocol 2010. Canberra: 
AIHW. Viewed 7 March 2013, 
<http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737421344>. 
Australian Government Department of Health 2013. Statistical Local Area Population 
Projections, 2011 (base) to 2026, Preliminary. Canberra: Australian Government Department 
of Health. Viewed October 2013, 
<http://www.health.gov.au/internet/main/publishing.nsf/Content/ageing-stats-
lapp.htm>. 
Barton M, Jacob S, Shafiq J, Wong KHW, Delaney G & Hanna T 2013. Review of optimal 
radiotherapy utilisation rates. Liverpool (NSW): Ingham Institute for Applied Medical 
Research. 
Cancer Institute NSW 2011. Cancer incidence and mortality: projections 2011 to 2021. 
Sydney: Cancer Institute NSW. 
Coorey M & Armstrong B 1998. Cancer incidence projections for Area and Rural Health 
Services in New South Wales. Sydney: NSW Cancer Council. 
Medicare Australia 2014. Medicare Australia statistics. Canberra: Medicare Australia. 
Viewed February 2014, 
<https://www.medicareaustralia.gov.au/statistics/mbs_item.shtml>. 
Moller B, Weedon-Fekjaer H & Haldorsen T 2005. Empirical evaluation of prediction 
intervals for cancer incidence. BMC Medical Research Methodology 5:21. 
QCCAT (Queensland Cancer Control Analysis Team) 2014. OASys (Oncology Analysis 
System). Brisbane: Queensland Health. Viewed 6 June 2014, 
<https://qccat.health.qld.gov.au/AboutOASys>. 
Smith D, Supramaniam R, Marshall V & Armstrong B 2008. Prostate cancer and 
prostate-specific antigen testing in New South Wales. Medical Journal of Australia 189(6). 
South Australian Cancer Registry 2013. Cancer in South Australia 2009—with projections to 
2012. Adelaide: South Australian Department for Health and Ageing. Viewed 15 April 2014, 
<www.health.sa.gov.au/pehs/health-statistics.htm>. 
Stokes B, Albion T, Otahal P & Venn A 2013. Cancer in Tasmania: incidence and mortality 
2010. Hobart: Menzies Research Institute Tasmania. 
Threlfall T & Thompson J 2010. Cancer incidence and mortality in Western Australia, 2009. 
Statistical Series number 91. Perth: Department of Health (Western Australia). 
Thursfield V, Staines C, Giles G & Farrugia H 2013. Cancer in Victoria: statistics and trends 
2012. Melbourne: Cancer Council Victoria. 
  Radiation oncology areas of need: cancer incidence projections 2014–2024 33 
Zhang X, Condon J, Dempsey K & Garling L 2014. Cancer in the Northern Territory 1991–
2010: incidence, mortality and survival. Darwin: Department of Health. 
 34 Radiation oncology areas of need: cancer incidence projections 2014–2024 
 
List of tables 
Table 2.1:  Incidence of all cancers combined, by jurisdiction: observed 2010 and projected  
2014 and 2024 ..................................................................................................................................... 5 
Table 2.2:  Projected incidence of all cancers combined, by HPR, 2014 to 2024: New South Wales ......... 7 
Table 2.3:  Projected incidence of all cancers combined, by HPR, 2014 to 2024: Victoria ........................... 9 
Table 2.4:  Projected incidence of all cancers combined, by HPR, 2014 to 2024: Queensland ................. 11 
Table 2.5:  Projected incidence of all cancers combined, by HPR, 2014 to 2024: Western Australia ....... 13 
Table 2.6:  Projected incidence of all cancers combined, by HPR, 2014 to 2024: South Australia ........... 15 
Table 2.7:  Projected incidence of all cancers combined, by HPR, 2014 to 2024: Tasmania...................... 17 
Table 2.8:  Projected incidence of all cancers combined, by HPR, 2014 to 2024: Australian Capital 
Territory ............................................................................................................................................ 18 
Table 2.9:  Projected incidence of all cancers combined, by HPR, 2014 to 2024: Northern Territory ..... 18 
Table A1:  Input variables to projections model, by state and territory ..................................................... 19 
Table B1:  MBS claims for Item 66655, by state and territory,  2002, 2013 and 2002–2013 ....................... 25 
Table B2:  Rebased estimated resident population, by state and territory, 1997 to 2010 (30 June) ........ 26 
Table B3:  Preliminary projected populations by HPR, 2014 to 2024: New South Wales ........................ 27 
Table B4:  Preliminary projected populations by HPR, 2014 to 2024: Victoria ......................................... 28 
Table B5:  Preliminary projected populations by HPR, 2014 to 2024: Queensland .................................. 29 
Table B6:  Preliminary projected populations by HPR, 2014 to 2024: Western Australia ....................... 30 
Table B7:  Preliminary projected populations by HPR, 2014 to 2024: South Australia ............................ 30 
Table B8:  Preliminary projected populations by HPR, 2014 to 2024: Tasmania ...................................... 31 
Table B9:  Preliminary projected populations, 2014 to 2024: Australian Capital Territory ..................... 31 
Table B10: Preliminary projected populations, 2014 to 2024: Northern Territory ..................................... 31 
CanCer series no. 85
Radiation oncology areas of need 
cancer incidence projections 2014–2024 
Radiation oncology areas of need: cancer incidence 
projections 2014–2024 presents cancer incidence 
projections at the jurisdictional health planning region 
level for 2014 to 2024. These projections were developed 
specifically for australian Government Department of 
Health planning purposes.
